Effect of Gene Polymorphisms on GLP-1 Receptor Agonists Response in Patients With T2DM
Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
This is an prospective study to evaluate the effect of gene polymorphisms on therapeutic
responses to glucagon like peptide-1 receptor agonist (GLP-1 RA) in patients with T2DM.
Phase:
N/A
Details
Lead Sponsor:
The Affiliated Hospital of Xuzhou Medical University